Related Experiment Video
Updated: Apr 25, 2026
A Murine Model of Stent Implantation in the Carotid Artery for the Study of Restenosis
Published on: May 14, 2013
Recurrent In-Stent Restenosis Treated With a Novel Technique: The Double-DCB Technique
An Shing Ang1, Thet Khaing1, Bharat Khialani2
1Department of Cardiology, Woodlands Hospital, Singapore.
Insights
Recurrent in-stent restenosis after percutaneous coronary intervention can be treated with a novel double-drug-coated balloon (DCB) technique. This approach avoids additional metal implants, offering a promising alternative for managing complex coronary artery disease.
Area of Science:
- Interventional Cardiology
- Cardiovascular Medicine
- Medical Technology
Background:
- Percutaneous coronary intervention (PCI) is crucial for acute and chronic coronary syndrome.
- In-stent restenosis (ISR) after PCI remains a significant challenge, increasing adverse outcomes.
- Current treatments for ISR often involve repeat stenting, adding more metal layers.
Abstract:
Percutaneous coronary intervention plays an important role in the management of both acute and chronic coronary syndrome. Despite advances in stent technology, in-stent restenosis remains a major Achilles heel in percutaneous coronary intervention and can confer high risk of adverse outcomes for patients. We describe a novel technique (the double-DCB technique) for the treatment of recurrent in-stent restenosis by applying 2 different drug-coated balloons, thereby avoiding the implantation of another layer of metal in our patients. More studies are required to understand the long-term outcomes of this technique and compare it with other treatment modalities in a randomized setting.
